Journey Medical Corp's ability to collect accounts receivable sequentially worsen to 2.5, indicating more challenging environment then in the first quarter 2026, but still, it is a far cry from any concerns. Journey Medical's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 146 days, from 125 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 180 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 1421, from overall ranking in the first quarter 2026 at 3112.

What is Receivable Turnover Ratio?
What is Journey Medical Corp Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

DERM Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	131.69 %	38.65 %	191.11 %	68.52 %	49.49 %
Y / Y Revenue Change	23.33 %	21.48 %	18.05 %	20.52 %	1.04 %
Receivable Turnover Ratio (TTM)	2.5	2.93	3.04	3.84	4.13
DERM's Total Ranking	# 1421	# 3112	# 2906	# 1428	# 1089
Accounts Receivable average collection period days	146	125	120	95	88
Seq. Receivable Change	45.03 %	-16.09 %	65.62 %	14.95 %	-13.21 %
Seq. Revenue Change	15.97 %	-0.73 %	-8.8 %	17.47 %	14.23 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 45
Healthcare Sector	# 181
Overall Market	# 1421

Receivable Turnover Ratio Statistics
High	Average	Low
1.15	0.5	0.01
(Mar 31 2024)		(Mar 31 2018)

DERM Company Profile • Back to DERM Efficiency Comparisons • Compare DERM Receivables Turnover Ratio to its Competitors

Financial Statements
Journey Medical's Accounts Receivable	$ 36 Millions	Visit DERM's Balance sheet
Journey Medical's Sales TTM	$ 68 Millions	Visit DERM's Income Statement
Sources of DERM's Revenues		Visit DERM's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
DERM's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
DERM's Growth Rates	DERM's Roa	DERM's Inventory Turnover Ratio	DERM's Dividend Comparisons
DERM's Profitability Ratios	DERM's Roi	DERM's Asset Turnover Ratio	DERM's Dividend Growth
DERM's Valuation Ratios	DERM's Roe	DERM's Financial Strength Ratios	DERM's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Elutia Inc	5.16	$ 11.353 Millions	$ 2.198 Millions
Opus Genetics Inc	5.13	$ 9.856 Millions	$ 1.921 Millions
Carlsmed Inc	5.13	$ 62.457 Millions	$ 12.175 Millions
West Pharmaceutical Services Inc	5.12	$ 3,326.900 Millions	$ 649.250 Millions
Elanco Animal Health Incorporated	5.11	$ 5,020.000 Millions	$ 982.000 Millions
Repligen Corp	5.09	$ 785.101 Millions	$ 154.205 Millions
Indivior Pharmaceuticals Inc	5.05	$ 1,333.000 Millions	$ 264.000 Millions
Inspiremd Inc	5.05	$ 10.502 Millions	$ 2.082 Millions
Sarepta Therapeutics Inc	5.04	$ 1,974.344 Millions	$ 391.403 Millions
Pacific Biosciences Of California Inc	5.04	$ 159.315 Millions	$ 31.630 Millions
Amphastar Pharmaceuticals Inc	5.01	$ 730.019 Millions	$ 145.768 Millions
Invivyd Inc	5.01	$ 58.365 Millions	$ 11.660 Millions
Zimmer Biomet Holdings Inc	5.00	$ 8,508.800 Millions	$ 1,700.200 Millions
Abbvie Inc	4.99	$ 64,386.000 Millions	$ 12,915.250 Millions
Pfizer Inc	4.98	$ 63,696.000 Millions	$ 12,802.250 Millions
Stereotaxis Inc	4.98	$ 29.892 Millions	$ 6.008 Millions
Agilent Technologies inc	4.96	$ 7,372.000 Millions	$ 1,487.500 Millions
Cytosorbents Corporation	4.93	$ 35.663 Millions	$ 7.229 Millions
Geron Corporation	4.93	$ 204.301 Millions	$ 41.467 Millions
Champions Oncology Inc	4.90	$ 60.662 Millions	$ 12.388 Millions
Ligand Pharmaceuticals Incorporated	4.89	$ 290.542 Millions	$ 59.389 Millions
Viatris Inc	4.89	$ 14,737.300 Millions	$ 3,015.075 Millions
Biomerica Inc	4.86	$ 4.453 Millions	$ 0.916 Millions
Kura Oncology Inc	4.86	$ 77.225 Millions	$ 15.884 Millions
Mirum Pharmaceuticals Inc	4.86	$ 618.067 Millions	$ 127.234 Millions
Bellevue Life Sciences Acquisition Corp	4.86	$ 1.809 Millions	$ 0.372 Millions
Ultragenyx Pharmaceutical Inc	4.85	$ 717.212 Millions	$ 147.886 Millions
Ptc Therapeutics inc	4.78	$ 1,008.754 Millions	$ 210.915 Millions
Personalis Inc	4.75	$ 69.669 Millions	$ 14.676 Millions
Privia Health Group Inc	4.75	$ 2,358.069 Millions	$ 496.945 Millions

Date modified: 2026-09-26T07:41:04+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.